Balyasny Asset Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.6M | Buy |
3,247,463
+27,892
| +0.9% | +$143K | 0.03% | 556 |
|
2025
Q1 | $4.41M | Sell |
3,219,571
-59,625
| -2% | -$81.7K | 0.01% | 891 |
|
2024
Q4 | $10.1M | Buy |
3,279,196
+592,000
| +22% | +$1.83M | 0.02% | 673 |
|
2024
Q3 | $20.7M | Buy |
2,687,196
+2,410,187
| +870% | +$18.6M | 0.03% | 446 |
|
2024
Q2 | $2.38M | Buy |
+277,009
| New | +$2.38M | ﹤0.01% | 1009 |
|
2023
Q4 | – | Sell |
-844,377
| Closed | -$9.51M | – | 2273 |
|
2023
Q3 | $9.51M | Buy |
+844,377
| New | +$9.51M | 0.02% | 630 |
|
2022
Q2 | – | Sell |
-31,781
| Closed | -$241K | – | 2701 |
|
2022
Q1 | $241K | Buy |
+31,781
| New | +$241K | ﹤0.01% | 1629 |
|